Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2013.05.011
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Publisher
Elsevier BV